• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小鼠化学诱导肝细胞癌的两阶段模型。

Two-stage model of chemically induced hepatocellular carcinoma in mouse.

机构信息

Biomedical Research Center, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, People's Republic of China.

出版信息

Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.

DOI:10.3727/096504013X13747716581336
PMID:24063282
Abstract

The aim of this study was to develop an efficient and reproducible mouse model for hepatocellular carcinoma (HCC) research and assess the expression of two proto-oncogenes (c-myc and N-ras) and tumor suppressor gene p53 in the carcinogenic process. In this study, we found that diethylnitrosamine initiation with CCl4 and ethanol promotion could induce a short-term, two-stage liver carcinogenesis model in male BALB/c mice, the process of hepatocarcinogenesis including liver damage, liver necrosis/cell death, liver inflammation, liver proliferation, liver hyperplasia, liver steatosis, and liver cirrhosis and hepatocellular nodules, which mimicked the usual sequence of events observed in human HCC. We also identified that the increase in expression of the p53 gene is related to the proliferation of hepatocytes, whereas overexpression of the c-myc and N-ras genes is associated with hepatocarcinogenesis. This animal model may serve as a basis for recapitulating the molecular pathogenesis of HCC seen in humans.

摘要

本研究旨在建立一种高效且可重现的用于肝细胞癌(HCC)研究的小鼠模型,并评估两种原癌基因(c-myc 和 N-ras)和肿瘤抑制基因 p53 在致癌过程中的表达。在本研究中,我们发现二乙基亚硝胺(DEN)引发联合 CCl4 和乙醇促进可诱导雄性 BALB/c 小鼠的短期、两阶段肝致癌发生模型,肝致癌发生过程包括肝损伤、肝坏死/细胞死亡、肝炎症、肝增殖、肝增生、肝脂肪变性、肝硬变和肝细胞结节,这模拟了在人类 HCC 中观察到的通常的事件序列。我们还发现,p53 基因表达的增加与肝细胞的增殖有关,而 c-myc 和 N-ras 基因的过表达与肝癌发生有关。该动物模型可能作为模拟人类 HCC 分子发病机制的基础。

相似文献

1
Two-stage model of chemically induced hepatocellular carcinoma in mouse.小鼠化学诱导肝细胞癌的两阶段模型。
Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.
2
Protein phosphatase 2A promotes hepatocellular carcinogenesis in the diethylnitrosamine mouse model through inhibition of p53.蛋白磷酸酶 2A 通过抑制 p53 促进二乙基亚硝胺诱导的肝癌发生。
Carcinogenesis. 2014 Jan;35(1):114-22. doi: 10.1093/carcin/bgt258. Epub 2013 Jul 29.
3
Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.E2F-1在肝癌发生转基因小鼠模型中的双重功能。
Oncogene. 2000 Oct 19;19(44):5054-62. doi: 10.1038/sj.onc.1203885.
4
Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis.小鼠肝癌发生过程中卵圆细胞的分布及c-myc mRNA表达
Hepatobiliary Pancreat Dis Int. 2004 Aug;3(3):433-9.
5
The Differential Immunohistochemical Expression of p53, c-Jun, c-Myc, and p21 Between HCV-related Hepatocellular Carcinoma With and Without Cirrhosis.伴有和不伴有肝硬化的丙型肝炎病毒相关肝细胞癌中p53、c-Jun、c-Myc和p21的差异免疫组化表达
Appl Immunohistochem Mol Morphol. 2016 Feb;24(2):75-87. doi: 10.1097/PAI.0000000000000155.
6
CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.CYLD 通过 JNK 依赖的信号通路控制肝癌细胞中的 c-MYC 表达。
Carcinogenesis. 2014 Feb;35(2):461-8. doi: 10.1093/carcin/bgt335. Epub 2013 Oct 8.
7
Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.p53 基因敲除小鼠中转分化和去分化产生的肝细胞胆管细胞癌。
Cancer Sci. 2021 Aug;112(8):3111-3124. doi: 10.1111/cas.14996. Epub 2021 Jun 27.
8
Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.共表达c-myc和转化生长因子-α的转基因小鼠肝脏中肿瘤发生的演变
Am J Pathol. 1996 Aug;149(2):407-28.
9
Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice.有缺陷的DNA链断裂修复会导致染色体不稳定,并加速小鼠肝癌的发生。
Hepatology. 2008 Jun;47(6):2078-88. doi: 10.1002/hep.22194.
10
Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.联合血清和组织蛋白质组学研究应用于 c-Myc 转基因肝癌小鼠模型,鉴定出适合诊断和治疗干预策略的新型疾病调控蛋白。
J Proteome Res. 2011 Jul 1;10(7):3012-30. doi: 10.1021/pr101207t. Epub 2011 Jun 6.

引用本文的文献

1
The application of liver cancer organoids in tumour precision medicine: A comprehensive review.肝癌类器官在肿瘤精准医学中的应用:一项综述
ILIVER. 2025 Jul 5;4(3):100179. doi: 10.1016/j.iliver.2025.100179. eCollection 2025 Sep.
2
Experimental Models of Hepatocellular Carcinoma-A Preclinical Perspective.肝细胞癌的实验模型——临床前视角
Cancers (Basel). 2021 Jul 21;13(15):3651. doi: 10.3390/cancers13153651.
3
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer.基于微小RNA的肝硬化和肝癌小鼠模型预防研究
Mol Ther Nucleic Acids. 2019 Mar 1;14:239-250. doi: 10.1016/j.omtn.2018.11.018. Epub 2018 Dec 6.
4
Butaselen prevents hepatocarcinogenesis and progression through inhibiting thioredoxin reductase activity.但巴西硒通过抑制硫氧还蛋白还原酶活性来预防肝癌的发生和进展。
Redox Biol. 2018 Apr;14:237-249. doi: 10.1016/j.redox.2017.09.014. Epub 2017 Sep 22.
5
Alcohol and Cancer: Mechanisms and Therapies.酒精与癌症:作用机制与治疗方法
Biomolecules. 2017 Aug 14;7(3):61. doi: 10.3390/biom7030061.
6
Disruptive environmental chemicals and cellular mechanisms that confer resistance to cell death.具有破坏作用的环境化学物质以及赋予细胞对死亡抗性的细胞机制。
Carcinogenesis. 2015 Jun;36 Suppl 1(Suppl 1):S89-110. doi: 10.1093/carcin/bgv032.
7
MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.肝癌中的微小RNA:一种用于研究发病机制和新型治疗方法的模型
Cell Death Differ. 2015 Jan;22(1):46-57. doi: 10.1038/cdd.2014.136. Epub 2014 Sep 5.
8
Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.催乳素通过限制 c-Myc 在小鼠中固有免疫的激活来预防肝细胞癌。
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11455-60. doi: 10.1073/pnas.1404267111. Epub 2014 Jul 21.